NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Languages English Remove constraint Languages: English Copyright Public domain Remove constraint Copyright: Public domain

Search Results

4. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

7. ACF cannot ensure that all child victims of abuse and neglect have court representation

9. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

13. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

15. Access and use of electronic health information by individuals with cancer: 2017-2018

17. Access to preventive services without cost-sharing: evidence from the Affordable Care Act

18. The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

20. Acne vulgaris: establishing effectiveness of drugs intended for treatment

23. Adaptive designs for clinical trials of drugs and biologics

24. Addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts

27. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

28. Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees

29. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

31. Advancement of emerging technology applications for pharmaceutical innovation and modernization

33. Advancing primary prevention in human services. Key considerations for administrators and practitioners

34. Advancing primary prevention in human services. Key considerations for policy designers and funding partners

35. Advancing primary prevention in human services. Opportunities for people with lived experience

36. Advancing primary prevention in human services: convening findings

37. Advancing research on intersections of child welfare and Medicaid using linked data from the CCOULD project

39. Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries

42. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

43. The aging services network: accomplishments and challenges in serving a growing elderly population

44. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

46. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

48. Allergic rhinitis: developing drug products for treatment

49. Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate